JUN 13, 2018 12:43 PM PDT

Vitamin A Gives Immune System Power to Fight Tuberculosis

WRITTEN BY: Kara Marker

Multidrug-resistant tuberculosis bacteria are a serious health concern for the global population, but a new finding offers a new therapeutic solution that may be impervious to the development of resistance: vitamin A.

Histopathology of tuberculosis-infected lung tissue, specifically inflammation in the tissue lining the lungs. Credit: Yale Rosen

From Trinity College Dublin, scientists show how vitamin A supports the lung immune system in the fight against tuberculosis (TB), indicating a new type of immunotherapy that could help treat the disease, which killed 1.7 million people in 2016. TB is considered to be the leading cause of death from infectious disease across the globe.

A bacterial infection caused by the organism Mycobacterium tuberculosis, TB usually involves the lungs, but bacteria can invade the kidney, spine, brain, and other organs. A TB infection can be latent, causing no symptoms, but the infected person can still pass on the disease to someone else, whose immune system may not be strong enough to prevent a full-on TB infection.

Symptoms of such an infection include bad cough, chest pain, and coughing up blood or phlegm from deep in the lungs. The Bacille Calmette-Guerin vaccine prevents TB infection (although not 100 percent of the time), and it is often used in infants and young children in countries outside of the United States. Multiple-drug resistant strains of TB are particularly dangerous, as physicians are either forced to use harsh drugs that harm the patient while treating the infection or run out of therapeutic options completely.

Interestingly, vitamin A deficiency is relatively common in TB patients, and people with this deficiency are ten times as likely to develop the disease. Needless to say, vitamin A soon became the main topic of many studies.

Vitamin A is known for its role in immune function, vision, reproduction, and cellular communication. It’s found in dairy products, fish, meat, and other animal sources.

In the new study, researchers investigated the relationship between vitamin A and the immune system during TB infection. They found that increased vitamin A consumption greatly improves an immune process called autophagy. Fulfilled mostly by phagocytic cells like macrophages, autophagy consists of breaking down and recycling dead and dying cells, cellular debris, and pathogens. This is all through a process called phagocytosis, where cells engulf and break down the object of destruction.

Additionally, researchers found that vitamin A consumption enhances the phagocytic activity of macrophages during a TB infection. Paired with the finding from a past study that vitamin A also promotes anti-inflammatory activity, researchers were assured that they were onto something.

“TB remains a pressing global issue affecting millions worldwide. The high prevalence of vitamin A deficiency is a major driver in the global TB epidemic,” concluded lead author Dr. Sharee Basdeo Trinity. “Our next step will be to translate our research from the laboratory bench to the bedside. If this works out, we would plan to add vitamin A to the existing drug therapies to improve the outcome for our patients."

The present study was published in the American Journal of Respiratory Cell and Molecular Biology.

Sources: Centers for Disease Control and Prevention, National Institutes of Health Office of Dietary Supplements, Trinity College Dublin

About the Author
  • I am a scientific journalist and enthusiast, especially in the realm of biomedicine. I am passionate about conveying the truth in scientific phenomena and subsequently improving health and public awareness. Sometimes scientific research needs a translator to effectively communicate the scientific jargon present in significant findings. I plan to be that translating communicator, and I hope to decrease the spread of misrepresented scientific phenomena! Check out my science blog: ScienceKara.com.
You May Also Like
JAN 18, 2021
Immunology
Arthritis Drug Approved for Critically Ill COVID Patients
JAN 18, 2021
Arthritis Drug Approved for Critically Ill COVID Patients
Critically ill COVID patients in the U.K. may receive an arthritis drug after a study showed that treatment lowered mort ...
APR 01, 2021
Immunology
Tumor-Killing 101: Vaccine Trains Immune Cells to Keep Skin Cancer at Bay
APR 01, 2021
Tumor-Killing 101: Vaccine Trains Immune Cells to Keep Skin Cancer at Bay
Cancer researchers have developed a therapeutic vaccine for melanoma, a deadly form of skin cancer. Instead of protectin ...
APR 15, 2021
Immunology
COVID Vaccines Protect Breastfeeding Babies Too
APR 15, 2021
COVID Vaccines Protect Breastfeeding Babies Too
Good news for families of newborns: A new study shows that breastfeeding mothers who receive a COVID vaccine share prote ...
APR 20, 2021
Immunology
Scientists Map the Genetic Landscape of COVID Infections
APR 20, 2021
Scientists Map the Genetic Landscape of COVID Infections
Scientists have identified 65 human immune genes activated during SARS-CoV-2 infection. This finding provides valuable i ...
APR 22, 2021
Immunology
Healthy, Young People Are Getting Reinfected With COVID
APR 22, 2021
Healthy, Young People Are Getting Reinfected With COVID
If you’re young and healthy and you’ve had COVID, your body will produce protective antibodies that guard yo ...
APR 28, 2021
Health & Medicine
Irish National Surveillance Study Finds that Underlying Chronic Conditions Worsen COVID-19 Outcomes
APR 28, 2021
Irish National Surveillance Study Finds that Underlying Chronic Conditions Worsen COVID-19 Outcomes
Globally, more than 2 million people have died with SARS-CoV-2 infection. The World Health Organization (WHO) estimates ...
Loading Comments...